Previous Article | Next Article ![]()
Journal of Bacteriology, July 2002, p. 3756-3758, Vol. 184, No. 13
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.13.3756-3758.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Physiology, Johns Hopkins University Medical School, Baltimore, Maryland 21205
Received 4 January 2002/ Accepted 10 April 2002
|
|
|---|
|
|
|---|
-helical conformation (9, 13, 19). Because there is as yet no crystallographic structure to guide an analysis, the study of helix relationships and helix function in members of the MFS has relied heavily on site-directed mutagenesis and the modification chemistry it affords. We have applied these techniques to the study of UhpT, the Pi-linked hexose phosphate antiport carrier of Escherichia coli (14, 15, 21). In previous work, Asp388 and Lys391, located in the 11th transmembrane segment (TM11) of this transporter, were identified as participants in an intrahelical salt bridge (7). Study of this ion pair indicated that both positions 388 and 391 might lie on the UhpT translocation pathway since D388C and K391C single-cysteine variants are sensitive to the membrane impermeant, thiol-reactive probe p-chloromercuribenzosulfonate but are unaffected when treatment is in the presence of substrate (8). Further analysis indicated that these two positions might also function as determinants of substrate specificity. Derivatives having an uncompensated cationic charge (the D388C and D388K/K391C variants) are gain-of-function mutants in which substrate preference is strongly biased in favor of phosphoenolpyruvate (PEP), a substrate that carries one more negative charge than sugar 6-phosphate (8). Here, by using the lysine-reactive agent pyridoxal 5-phosphate (PLP), we provide evidence that the lysine introduced into these gain-of-function variants serves as a receptor for the reactive aldehyde of PLP, suggesting that this lysine is also poised to interact with the anionic carboxyl brought into the translocation pathway by PEP.
Strain RK5000 [araD139
(argF-lac)U169 relA1 rpsL150 thi gyrA219 non metE780
(ilvB-uhpABCT')2056 recA] served as the host for tests of function of plasmid-encoded UhpT (23). Plasmid pTrc(HisC0S6) encodes the histidine-tagged, cysteineless UhpT that served as the parent for the D388C and D388K/K391C derivatives described in this study (7). To assay transport function, overnight cultures were diluted 200-fold into either Luria-Bertani broth plus antibiotics (100 µg of streptomycin/ml, 100 µg of ampicillin/ml) or M63 minimal medium (17) (pH 7) containing thiamine (2 µg/ml), required amino acids (50 µg/ml), necessary antibiotics, and 0.2% glucose as the carbon source. Cells were grown at 37°C to a density of 2 x 108 to 5 x 108 cells/ml, harvested by centrifugation, and then washed twice and resuspended in buffer A (50 mM morpholinepropanesulfonic acid [MOPS]-K, 100 mM K2SO4, 1 mM MgSO4, pH 7) at an optical density at 660 nm of 1.4, which is equivalent to about 2 x 109 cells/ml. After equilibration at room temperature, tests of Pi transport ([32P]KPi) was obtained from Perkin Elmer Life Sciences) were initiated by adding a 1/20th volume of labeled substrate (final concentration, 100 µM). At indicated times, aliquots were removed for filtration on Millipore filters (0.45-µm pore size) followed by two washes with 5 ml of buffer A lacking MgSO4. To monitor PLP inhibition of glucose-6-phosphate (G6P) and PEP transport, cells were first incubated with and without PLP (1 µM to 1 mM) for 10 min at room temperature to allow Schiff base formation with any exposed lysine residues (11). Any Schiff base(s) formed was reduced by a subsequent 10-min exposure to 15 mM NaBH4 to yield the chemically stable product N-phosphopyridoxal-lysine (11). Aliquots were then filtered to remove additives, and after two washes with 5 ml of buffer A, tests of transport were initiated by overlaying cells (on the filter) with buffer A containing 50 µM radiolabeled G6P or PEP ([14C]G6P and [14C]PEP were obtained from Perkin Elmer Life Sciences and Amersham Pharmacia Biotech, respectively). To assess substrate protection, the same protocol was used, except that cells were incubated with either 1 mM unlabeled substrate or 1 mM unlabeled substrate plus PLP before tests of transport.
As a cofactor, PLP functions by facilitating an array of mechanistically related reactions, almost always involving an interaction with a lysine residue during the course of catalysis (10, 22). It is this selectivity that makes PLP a useful reagent for analyzing both the location and function of lysyl groups in membrane transport proteins (1-3, 6, 12, 18), including UhpT. However, since PLP resembles UhpT's natural substrates in overall size, shape, and charge, it was important to first determine whether this compound is transported by cysteineless UhpT and its D388C and D388K/K391C derivatives. Since these variants display normal levels of Pi self-exchange (8) (Fig. 1), we could address this issue by measuring the effectiveness with which added substrate (G6P, PEP, or PLP) caused the loss of Pi during heterologous exchange of internal substrate (Fig. 1). As expected, the addition of G6P, but not of PEP, led to a marked loss of internal phosphate in cells carrying cysteineless UhpT, while PEP caused nearly equivalent Pi efflux from the D388C and D388K/K391C variants. By contrast, reduced Pi efflux occurred when a low-affinity substrate was added (G6P for the D388C and D388K/K391C gain-of-function mutants and PEP for cysteineless UhpT). In these latter cases, we attribute residual Pi efflux to the use of these substrates at a concentration (1 mM) at or above their likely Km values for transport (8). PLP induced an even smaller efflux of Pi, suggesting that significant Pi/PLP exchange does not occur for the UhpT variants analyzed here. A low level of Pi efflux might be attributed to PLP functioning as an inhibitor of transport, and in the case of both the D388C and D388K/K391C mutants, this may be the case (see below). However, PLP acts as a poor inhibitor of G6P transport by cysteineless UhpT (Table 1), indicating that the residual Pi efflux exhibited by this strain upon addition of PLP is likely due to this compound being, at best, a poor UhpT substrate (Km >> 1 mM).
![]() View larger version (18K): [in a new window] |
FIG. 1. Substrate transport by UhpT and its derivatives. Pi transport by cysteineless (A), D388K/K391C (B), and D388C (C) UhpT. Cells (grown in M63 minimal medium to repress other phosphate systems) were incubated with radiolabeled Pi. At the time point indicated by the arrow, the control tube was divided into four portions and each portion was given either additional buffer A ( ) or buffer A containing 1 mM unlabeled Pi ( ), G6P ( ), PEP ( ), or PLP (). Data from three separate trials were normalized to the transport values at the time of addition (Pi accumulation at this time ranged from 80 to 120 nmol/mg of protein) and are shown as means ± standard errors.
|
|
View this table: [in a new window] |
TABLE 1. UhpT function in TM11 variants exposed to PLP
|
![]() View larger version (10K): [in a new window] |
FIG. 2. Inhibition of UhpT variants by PLP. Inhibition of G6P (cysteineless UhpT [ ]) and PEP (D388C [] and D388K/K391C [ ] derivatives) transport after treatment with PLP (1 µM to 1 mM) and NaBH4. Data from three independent experiments were normalized to the transport values after treatment with NaBH4 alone and are shown as means ± standard errors using the method of Dixon (4). K0.5 values for UhpT variants under these conditions are shown in Table 1.
|
We thank Robert Kadner for the gift of strain RK5000.
|
|
|---|
-helix that carries determinants of substrate selectivity. J. Biol. Chem. 276:25107-25113.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»